Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
MINNEAPOLIS, March 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., has secured a license agreement with …